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Abstract 
With advances in tissue engineering, the possibility of regenerating injured tissue or failing 
organs has become a realistic prospect for the first time in medical history. Tissue engineering 
– the combination of bioactive materials with cells to generate engineered constructs that 
functionally replace lost and/or damaged tissue – is a major strategy to achieve this goal. One 
facet of tissue engineering is biofabrication, where three-dimensional tissue-like structures 
composed of biomaterials and cells in a single manufacturing procedure are generated. Cell-
laden hydrogels are commonly used in biofabrication and are termed “bio-inks”. Hydrogels 
are particularly attractive for biofabrication as they recapitulate several features of the natural 
extracellular matrix and allow cell encapsulation in a highly hydrated mechanically supportive 
three-dimensional environment. Additionally, they allow for efficient and homogeneous cell 
seeding, can provide biologically-relevant chemical and physical signals and can be formed in 
various shapes and biomechanical characteristics. However, while advances in modifying 
hydrogels for enhanced bioactivation, cell survival and tissue formation, little attention has so 
far been paid to optimize hydrogels for the physico-chemical demands of the biofabrication 
process. The resulting lack of hydrogel bioinks have been identified as one major hurdle for a 
more rapid progress of the field. In this review we summarize and focus on the deposition 
process, the parameters and demands of hydrogels in biofabrication, with special attention to 
robotic dispensing as an approach that generates constructs of clinically relevant dimensions. 
We aim to highlight this current lack of effectual hydrogels within biofabrication and initiate 
new ideas and developments in the design and tailoring of hydrogels. The successful 
development of a “printable” hydrogel that support cell adhesion, migration and 
differentiation will significantly advance this exciting and promising approach for tissue 
engineering. 
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1. Introduction 
Tissue engineering (TE) aims for the full restoration of damaged or degenerated tissues and 
organs through the use of TE, cell and growth factor delivery. Tissue-engineered constructs 
will have to mimic a certain degree of the native complexity of the tissue in order to assist in 
restoration of the full structure and functionality of the tissue. Traditionally, the three main 
components of TE are cells, scaffolds and growth factors and they are combined to form a 
construct that can be immediately implanted or incubated in vitro prior to implantation. A 
scaffold can successfully deliver cells and/or growth factors to a damaged or degenerated 
tissue or organ, while simultaneously providing temporal mechanical support for the period 
the newly formed tissue matures. However, the three-dimensional (3D) constructs that have 
been generated for these scaffold-based or scaffold-guided TE approaches are typically based 
on the random distribution of cells, matrix, and bioactive cues, since their manufacturing does 
not allow the control of specific distribution. Mimicking the biological and functional 
organizational complexity of native tissues is now regarded as the next challenge in the full 
regeneration of tissues. 
 
To address this challenge, additive manufacturing (AM) technology has been employed to 
generate bio-engineered 3D structures to replicate the complex nature of tissue.[1] In this 
approach, termed “biofabrication”,[2, 3] biological structures for TE, pharmacokinetic or basic 
cell biology studies (including disease models) are created by an computer-aided 
manufacturing process for patterning and assembling living and non-living materials with a 
prescribed 3D organization.[4] The resulting shape can be customized, and include open inner 
structures that improve the supply of nutrients towards embedded cells.[5] Moreover, the 
fabricated structures can be used to study interactions between different cells and/or bioactive 
compounds,[6] but could also lead to functional tissue equivalents,[7] and potentially, to whole 
functioning organs.[8] Recent investigations have, for example, adopted biofabrication for the 
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engineering of 3D constructs with the organizational features of different tissues, including 
skin,[9, 10] meniscus,[11] aortic valves,[12] cartilage,[13, 14] bone,[15] and blood vessels.[16] 
 
Whilst AM technologies, as applied in the processing of metals, ceramics and thermoplastic 
polymers have inspired the field of biofabrication, these “classic” AM approaches generally 
involve the use of organic solvents, high temperatures or crosslinking agents that are not 
compatible with living cells and/or bioactive proteins. Hydrogels can be processes under more 
cell friendly conditions and often classified in the biofabrication field as “bioinks”. From a 
biological point of view, high water content hydrogels are attractive candidates for the 
incorporation of cells and bioactive compounds, because they can provide an instructive, 
aqueous 3D environment, simulating the natural extracellular matrix.[15] 
 
Historically, hydrogels used in tissue engineering applications are predominantly based on 
naturally derived polymers, including alginate, gelatin, collagen, chitosan, fibrin and 
hyaluronic acid.[19-21] Cells benefit from the abundance of chemical signals present in these 
hydrogels, resulting in high viability and proliferation rates.[19, 22] These signals can also be 
used to induce the formation of specific neo-tissues,[19, 20, 23] however, due to batch-to-batch 
variation and the sensitivity of cells (especially stem cells) to these variations, reproducibility 
of constructs often remains complicated. In addition, implementation of these materials in 
biofabrication can be challenging due to their variable printability. 
In contrast to hydrogels based on natural polymers, 3D printed structures with high shape 
fidelity can be obtained with polymers based on synthetic networks, like poly(ethylene 
glycol)[24] and pluronics[25-27]. However, these hydrogels provide embedded cells with an inert 
environment without active binding sites,[28] often resulting in low cell viability.[25-27] In order 
to improve control over cellular differentiation in these gels, bioactive compounds have to be 
added or grafted to the network, like peptide sequences[29] and growth factors.[20, 30] Peptide 
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sequences can modulate cellular behavior by providing binding sites in otherwise inert 
hydrogels,[31] whereas growth factors can further direct cellular differentiation in order to 
regenerate a specific tissue type. There already are a number of reviews on the mandatory 
biological characteristics of hydrogels for biomedical applications and this goes beyond the 
scope of this review. For further reading we recommend recent reviews by Seliktar[22] and by 
DeForest and Anseth[28]. 
 
The present review will focus on the physicochemical aspects important for the development 
and characterization of hydrogels for biofabrication. Despite the fact that photocuring 
methods, such as two-photon polymerization[32] and stereolithograpy[33] can also yield 
organized 3D cell-laden hydrogel structures, their working principles do not involve 
deposition of gels and cells and hence pose different demands regarding hydrogel properties. 
Therefore, these techniques fall outside the scope of the current review. Here, we guide the 
reader in making choices regarding available approaches to tailor existing hydrogel platforms 
by means of physicochemical modification. Finally, current developments in hydrogels that 
could impact on the composition and properties of future hydrogel bioinks will be discussed. 
 
2. The Biofabrication Window 
Although major progress has been made with both natural and synthetic hydrogels in 
biofabrication,[34] bioinks have some significant complications regarding the required physical 
and biological properties. The central problem is that the fabrication of complex, tissue-like 
structures with high resolution dictates narrow boundaries for the physical properties of the 
hydrogels. Adittionally, the hydrogel construct should facilitate migration, proliferation and 
differentiation of the embedded and endogenous cells. Thereby, biofabrication imposes 
opposing requirements on the properties of materials and specifically the lack of such 
versatile hydrogel systems has been coined as an important factor restraining further progress 
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in this field.[1, 8, 35, 36-38] The traditional approach to improve printability of hydrogels has been 
increasing the polymer concentration or crosslink density.[39, 40] Highly crosslinked hydrogels 
serve as a stiff construction material as represented by the blue fabrication window (Fig. 1). 
On the contrary, cells thrive best in an aqueous environment, in which their migration and 
matrix deposition is not limited by a dense polymer network,[28] represented by the yellow cell 
culture window (Fig. 1). Unfortunately, hydrogels with a low extend of crosslinks lack the 
ability to maintain their imposed shape on fabrication, resulting in a low shape-fidelity and 
limited overall mechanical properties. Therefore, most constructs have been fabricated with a 
moderate degree of hydrogel crosslink densities, represented by the green “traditional” 
biofabrication window (Fig. 1). However, since hydrogels which fit in this window 
compromise on biological, as well as fabrication properties, there is a need to shift this 
biofabrication window in order to achieve high shape-fidelity with hydrogels that facilitate 
maximal cell and tissue compatibility (“novel strategies” (Fig. 1)). 
 
Hydrogels for biofabrication should allow the translation of the computer-aided design (CAD) 
to a tissue construct that potentially contains intricate internal and/or external organizational 
structures. This requires a high degree of control over the deposition process, which is closely 
associated with the printability of the hydrogel. The printing of inks on paper is well 
documented with various available tests that are taking in account surface and structural 
properties of the paper, however quantification of printability of ink on paper remains 
difficult.[41] Standardized tests to evaluate the capacity of hydrogels to be printed do not yet 
exist. Obviously, an important outcome parameter from a physical point of view would be the 
geometric accuracy or shape fidelity of the generated constructs. As such, there is a strong 
need for methods of geometry comparison of tissue-engineered constructs that go beyond 
simple visual inspection, manual measurements using rulers or calipers[42] and photographs.[11, 
40, 43]
 Optical methods have been developed to assess the geometric fidelities of tissue 
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constructs using laser triangulation.[42] Although this yields valuable data on the outer 
contours of homogeneous solid tissue replacements, such as for the meniscus, this technique 
will not visualize the potentially more intricate internal geometry. More recently, Murphy et 
al.[10] evaluated properties relevant to bioprinting, including printability, of a range of 
available hydrogels. In an attempt to quantify the printability, deviation of a 1.0 x 1.0 cm 
printed square area was determined. Although the authors were challenged by the fact that not 
all hydrogels could be reproducibly processed by the printer, this allowed for an, albeit rough, 
quantification, of the printability. Nevertheless, the fabrication of tissue structures is likely to 
require a significantly higher resolution than what could be evaluated in this approach. In 
view of this, the visualization of the difference between a computer design and a µCT 
generated image of a tissue construct, as represented in a heat map,[44] is a promising 
development, despite the fact that this will not discriminate between different hydrogels in a 
single generated tissue blueprint. 
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3. Hydrogel Based Biofabrication Systems 
The use of hydrogels as a carrier for cells and/or bioactive compounds has been described for 
many deposition-based biofabrication approaches.[15, 37] Briefly, these can be divided in 
methods based on laser-induced forward transfer, inkjet printing (both thermal and 
piezoelectric) and robotic dispensing (Fig. 2). Each technique demanding very specific 
requirements for characteristics of the hydrogel-based bioinks, with regards to their rheology 
and post-curing rate in order to achieve reliable fabrication of 3D constructs. 
 
3.1.  Laser-Induced Forward Transfer 
Laser-induced forward transfer technology refers to the use of a donor slide covered with a 
laser energy absorbing layer and a layer of cell-containing bioink.[45] The focused laser pulses 
cause local evaporation of the absorbing layer that, in turn, generates a high gas pressure 
propelling the bioink compound towards the collector slide (Fig. 2). This technology allows 
for the precise deposition of materials and (high densities of) cells in relatively small 3D 
structures without negatively affecting viability or cellular function.[45, 46] It is a nozzle-free 
approach and is therefore not affected by clogging issues. It has successfully been used with 
bioinks with a wide range of viscosities (1-300 mPa/s). Nevertheless, the high resolution of 
this process complicates even distribution of cells over the ejected drops, requires rapid 
gelation kinetics to achieve high shape fidelity and does result in a relatively low overall flow 
rate (Fig. 2). Consequently, the generation of larger and thus clinically relevant 3D constructs 
is time-consuming, hampering the successful translation towards widespread application. 
 
3.2. Inkjet Printing 
Usually, inkjet printing in the biofabrication field is defined as the dispensing through a small 
orifice and precise positioning of very small volumes (1-100 picolitres) of bioink (PBS, cell 
culture media and/or hydrogel) on a substrate.[2] For the inkjet printing of cells thermal and 
piezo-electric inkjet printing are the two most commonly adopted approaches. For thermal 
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inkjet printing (Fig. 2), small volumes of the printing fluid are vaporized by a micro-heater to 
create the pulse that expels droplets from the print head.[47] The generated heat and resulting 
evaporation do result in stress for the deposited cells[36] and causes transient pores in the cell 
membrane.[48] In piezoelectric inkjet printing (Fig. 2), on the other hand, no heating is used, 
but a direct mechanical pulse is applied to the fluid in the nozzle by a piezoelectric actuator, 
which causes a shock wave that forces the bioink through the nozzle. 
 
Inkjet printing has successfully been applied for accurate deposition of cells[49] and even 
allows for the generation of, albeit small, 3D structures.[50] One of the main restrictions of the 
inkjet technology is perhaps the low upper limit of the viscosity for the ink (Table 1), which is 
in the order of 0.1 Pa/s,[51] complicating the deposition of higher viscous natural extracellular 
matrix materials.[52] As small droplets of this ink are deposited onto a substrate with high 
velocity, the low viscosity will facilitate spreading of the droplet on the surface upon impact. 
This impedes building up 3D constructs, for which inkjet technology originally was not 
developed. Moreover, most researchers in this area have been using commercially available 
inkjet printers, which are designed for dispensing low-viscous inks -not containing particles 
measuring over 1 µm- at high resolution. Since this involves channels and orifices measuring 
not much larger than the diameter of a cell, challenges regarding both cell viability and inkjet 
system reliability result.[53] In summary, as a consequence of the small droplet size and the 
diffusion-dependent gelation of inkjet printers results in a challenge to translate this 
technology to larger, more clinically relevant, sizes. 
 
3.3. Robotic Dispensing 
An alternative approach for the design and fabrication of organized 3D hydrogel constructs is 
based on dispensing systems. For this method, hydrogels with suspended cells are generally 
inserted in disposable plastic syringes and dispensed, either pneumatic, piston- or screw-
driven, on a building platform (Fig. 2). Rather than single droplets, robotic dispensing yields 
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larger hydrogel strands. In order to maintain the shape of the constructs after printing, 
hydrogels with higher viscosities are often used. Resolution that can be achieved with robotic 
dispensing is in the order of 200 mm, which is considerably lower compared to laser- or 
inkjet-based systems. Nevertheless, fabrication speed using robotic dispensing is consequently 
significantly higher (Table 1) and anatomically shaped constructs have successfully been 
generated (Fig. 3). Piston-driven deposition generally provides more direct control over the 
flow of the hydrogel from the nozzle, due to the delay of the compressed gas volume in the 
pneumatic systems. On the other hand, screw-based systems may give more spatial control 
and are beneficial for the dispensing of hydrogels with higher viscosities. To further improve 
the printing quality of the 3D constructs, deposition within high viscous crosslinking solutions 
has been explored.[54, 55] Cells have been deposited with high viability and no notable effects 
on differentiation capacity using both pneumatic and piston driven systems (see Table 2). 
Screw extrusion can generate larger pressure drops at the nozzle, which can potentially be 
harmful for embedded cells. Thus, the screw design needs to be specifically designed to 
accommodate biofabrication, rather then using off-the-shelf screws designed for other 
applications. Taken together, robotic dispensing allows the fabrication of organized constructs 
of clinically-relevant sizes within a realistic time frame, hence this technology is often 
regarded as the most promising.[37, 38] 
 
4. Key Hydrogel Properties in Biofabrication 
The suitability of a hydrogel for a specific biofabrication process mainly depends on its 
physicochemical properties under the conditions imparted by the specific biofabrication 
instrument. The development of robust hydrogel systems for biofabrication, i.e., hydrogels 
that are suitable for both fabrication and cell culture, remains a challenge (Fig. 1). The major 
physiochemical parameters that determine the printability of a hydrogel are its rheological 
properties and crosslinking mechanisms (Fig. 4). However, the specific processing parameters, 
such as nozzle gauge (Fig. 4), will consequently determine the shear stress the embedded cells 
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are exposed to, as well as the maximal time required for fabrication of a clinically relevant 
size (cm3-scale) construct (Fig. 4). Finally, once the hydrogel precursors have been printed 
and the cells have survived, the printed construct has to possess, develop or be endowed with 
shape fidelity and sufficient mechanical stability, for example by (post-processing) gelation as 
a result of crosslinking. 
 
These parameters are interlinked and important for the different biofabrication technologies, 
however, absolute numbers can be considerably different given the nature of the deposition 
process. For example, inkjet printing is generally limited to low maximum viscosities, while 
with robotic dispensing bioinks with higher viscosities can be processed. Accordingly, inkjet 
printing requires rapid gelation to allow fabrication of an intricate 3D structure. On the other 
hand, robotic dispensing will facilitate the maintenance of the initial shape after deposition of 
hihj viscous liquids allowing for gelation (crosslinking) of the generated structures post-
fabrication, as well as building large constructs in the x, y, z directions. This illustrates how 
the viscosity of the hydrogel forming solution dictates how quickly it needs to solidify. In 
addition, swelling or contraction characteristics of hydrogels must also be considered and 
taken in account when designing a biofabricated tissue construct of particular size. Moreover, 
care should be taken when applying different bioinks with dissimilar swelling behaviour, 
since this can be complicated due to limited grafting of the layers and deformation of the final 
construct. 
 
4.1. Rheology 
Rheology is the study of the flow of matter under application of an external force, and is 
therefore highly relevant to biofabrication. Nevertheless, its importance is underestimated, 
given the high number of investigations that do not take rheology into account when 
developing or evaluating hydrogels for biofabrication. In the instances that rheological data is 
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presented, it often lacks the clear correlation to the results of the deposition processes, 
underscoring the complexity of field of rheology and its poorly understood role in 
biofabrication. Here, we discuss the influence of number of rheological parameters on the 
biofabrication process. 
 
4.1.1 Viscosity 
Viscosity is the resistance of a fluid to flow upon application of a stress. In biofabrication, a 
high viscosity impedes both surface tension-driven droplet formation (particularly important 
for filament-based deposition techniques) and the collapse of deposited structures. The 
viscosity of a polymer solution, such as a hydrogel precursor, is predominantly determined by 
the polymer concentration and molecular weight. This is illustrated in Table 3 for a number 
of hydrogel forming polymers, including sodium alginate (typical molecular weight 200 kDa) 
and Lutrol F127 (molecular weight 12 kDa). As hydrogels of high polymer concentrations can 
be restrictive environments for cell proliferation, migration and tissue formation,[56] it seems 
logical to opt for low concentrations of high molecular weight polymers. This (besides the 
before mentioned inherent biofunctionality) may explain the popularity and success of 
naturally derived polymers in the field, as many have high molecular weights that have not 
been matched by the same extend by synthetic biodegradable alternatives so far. Viscosity of 
the bioink directly influences shape fidelity after deposition (Fig. 5). Low-viscous 20% 
gelatin methacrylamide (gelMA) solution forms droplets at the needle tip, resulting in the 
deposition of strands that spread out on the surface, while the increase in viscosity by orders 
of magnitude upon addition of 2.4% high molecular weight hyaluronic acid (HA), allows the 
formation of a filament rather than a droplet.[57] Consequently, high-fidelity 3D structures 
could be deposited in which horizontal pores exist in addition to the vertical pores. 
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Printing fidelity, thus, generally increases with increasing viscosity, and this is the major 
underlying reason why hydrogels are usually printed with lower accuracies and resolutions 
than thermoplastic polymers. However, an increase in viscosity implies an increase of the 
applied shear stress, which may be harmful for the suspended cells.[58] A plethora of long-
term studies on the influence of intermediate shear stress levels on cell attachment and 
behavior has been performed (e.g., [59] on endothelial cells). For example, at levels in the 
order of 1Pa endothelial cells may detach from a surface[60] and the morphology and 
metabolic activity of articular chondrocytes is significantly changed.[61] Much less is known 
about short-term exposure to very high shear stresses that may arise in printing nozzles and 
orifices, but cells appear quite resilient in this respect[62] as the viability of printed endothelial 
cells have been shown to not decrease for shear stress levels up to 1150 kPa,[39] which is 6 
orders of magnitude higher than typical values for detaching cells from a surface or 
influencing cell morphology and metabolism. Within the range of systems, hydrogels and 
cells used so far, cell viability was generally not severely affected although a (negative) 
influence of shear stress (higher speeds and thinner nozzles) has been observed for robotic 
dispensing based systems.[63] In inkjet printing, transient pores have been observed in the cell 
membrane of printed Chinese hamster ovary cells.[48] These pores, measuring approximately 
10 nm, did not negatively affect viability or apoptosis and were self-repaired within 2 hours. 
Their presence was even used to the benefit of allowing gene transfer through the pores. 
Besides viscosity, the geometry of the dispensing setup (dimensions of channels, nozzles 
and/or orifices) and flow rates are additional factors that influence shear stress. In other words, 
shear stresses may be reduced at the cost of loss of resolution (larger nozzles/orifices) or at 
the cost of flow rate. 
 
In addition to polymer concentration and molecular weight (as main contributors), viscosity 
further depends on the solubility parameter (influencing the polymer coil’s hydrodynamic 
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radius), shear rate, temperature and other specific interactions. This means more sophisticated 
adaptations, which are more likely to ensure proper cellular behavior, are available for 
improving the rheological behavior of hydrogels for biofabrication. 
 
4.1.2 Shear Thinning 
Shear thinning (also pseudo-plasticity) refers to the non-Newtonian behavior in which the 
viscosity decreases as shear rate increases.[64] It is caused by shear-induced reorganization of 
the polymer chains to a more stretched conformation, which leads to decreased entanglement 
and, therefore, viscosity. This phenomenon is, to a variable extent, exhibited by most 
polymeric systems. Particularly, shear thinning is observed for solution of polymers with high 
molecular weight. Sodium alginate is an example of a polymer that shows strong shear 
thinning behavior (Fig. 6).[65] At shear rates relevant for 3DF of hydrogels (100-500 s-1), the 
viscosity is approximately an order of magnitude lower than the plateau value at low shear 
rates. For higher concentrations, the relative reduction in viscosity induced by shear is even 
greater. This implies a decreased shear stress at the high shear rates that are present inside a 
nozzle or orifice during biofabrication, followed by a sharp increase in viscosity (resulting in 
a high printing fidelity) upon deposition (Fig. 7). 
 
4.1.3 Yield Stress 
Yield stress is a stress that that must be overcome to initiate flow. Generally interactions 
between polymer chains result in the formation of a fragile, physically crosslinked network, 
which is broken by shear forces (above the yield stress) and (slowly) reforms when the shear 
is removed. Where high viscosity only delays collapse of a deposited 3D structure, the 
presence of a yield stress can potentially prevent flow and collapse. For example, gellan gum 
is an anionic polysaccharide that can be crosslinked by cations to form physical networks.[66] 
When added to gelMA at tailored salt concentrations it forms a gel suitable for robotic 
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dispensing as it exhibits strong yield stress behavior (Fig. 7).[67] Besides improving printing 
fidelity, the presence of a yield stress also prevents cell settling in the hydrogel precursor 
reservoir. Other hydrogel systems that exhibit yield stress and shear-thinning have been 
developed more specifically for delivering cells or bioactive molecules into the body by 
injection from a syringe.[64] Among these systems are self-assembling peptide based 
hydrogels[68], recombinant protein hydrogels[69], colloidal systems[70], gels based on 
cyclodextrin inclusion complexes and block copolymers.[71] 
 
4.2. Crosslinking mechanisms for hydrogels 
Gelation of a printed hydrogel structure is necessary to preserve its shape; even structures 
constructed from the most viscous precursor solution will change shape due to shape and 
collapse at some point. The gelation can either be physical (based on reversible interaction), 
chemical (based on formation of covalent chemical bonds), or a subsequent cascade and 
combination of both processes (Fig. 8). 
 
4.2.1 Physical Crosslinking 
Physical crosslinking mechanisms rely on non-chemical interactions based on entanglements 
of high molecular polymer chains, ionic interactions, hydrogen bridges or hydrophobic 
interactions. Physically crosslinked hydrogels are the most prominent hydrogel class used for 
biofabrication processes. For example, the first robotic dispensing approach, as described by 
Landers et al.,[72] involved printing a physically crosslinked hydrogel into a liquid. Due to the 
buoyancy of the hydrogels in the liquid, printed constructs are supported, facilitating the 
generation of porosity in the x-, y-, and z-directions. Gelation is predominantly based on 
ionic-crosslinking or on a thermally-induced property change and it has been demonstrated 
that printing into a liquids can also be combined with chemical crosslinking.[73] This strategy 
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is still being applied, for example by the printing of hydrogels into perfluorinated 
hydrocarbon-liquids.[54] 
 
One reason for the popularity of physically crosslinked gels is that they have excellent 
compatibillity with fragile molecules (e.g. growth factors) and with living cells, because 
potentially harmful chemical crosslinking agents are avoided. With physically crosslinked 
hydrogels, as the name implies, non-covalent physical interactions between hydrophilic 
polymer chains exist that prevent the gel from (immediate) dissolution in an aqueous 
environment. Many physical interactions have been exploited to design such physically 
crosslinked hydrogels, these interactions include hydrogen bonding, ionic interactions 
(polyelectrolyte hydrogels), stereocomplex formation of polymers or polymer fragments of 
opposite chirality, and hydrophobic interactions (e.g. self-assembly peptides).[74, 75] 
 
4.2.1.1 Ionic Crosslinking 
Ionic crosslinking is therefore an important mechanism in biofabrication, particularly for 
biopolymers. For example, alginate is a polysaccharide that consists of mannuronic and 
glucuronic acid residues and that is highly soluble in water as Na-salt. However, upon 
addition of Ca2+ ions (or other di/trivalent cations) rapid gelation of alginate occurs. Since this 
crosslinking occurs under mild and physiological conditions, alginate gels have been studied 
as system for the controlled release of pharmaceutical proteins and for the entrapment of 
living cells for TE applications.[76] As a consequence alginate has been widely applied in 
biofabrication approaches (Table 2). In recent years, hydrogels have also been developed 
exploiting electrostatic interactions between particles (nano and or micro) of opposite charge 
dispersed in an aqueous systems. These gels are rapidly formed upon mixing of the particles 
of opposite charge, but become fluid above a certain shear stress, sufficient to break the 
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interactions between the charged particles, making them suitable as injectable drug delivery 
system and likely also for bioprinting.[77] 
 
4.2.1.2 Stereocomplex Crosslinking 
Stereocomplex formation occurs, for example, between poly(D-lactic acid) (PDLA) and 
poly(L-lactic acid) (PLLA), homopolymers of D- and L-lactic acid, respectively. When 
oligomers of D- and L-lactic acid are coupled to water-soluble polymers like dextran or 
polyethylene glycol, hydrogels are formed which are crosslinked by stereocomplexes 
composed of oligomers of opposite chirality. Stereocomplexation does not occur immediately 
upon mixing of the hydrogel building blocks, allowing their use as injectable systems for 
controlled drug/protein release and as scaffolds for entrapment of cells.[78] An additional form 
of complexation mechanisms is the formation of inclusion complexes. For example, 
cyclodextrins, cyclic oligosaccharides composed of R-1,4-coupled D-glucose units contain a 
hydrophobic internal cavity that can accommodate lipophilic guest molecules. Cyclodextrins 
have therefore been investigated for the solubilization of hydrophobic drugs, but also used for 
the design of super-molecular materials, including hydrogels. In this approach, hydrophilic 
polymers are derivatized with cyclodextrin units, which, upon mixing with a guest molecule-
derivatized polymer, result in the formation of a hydrogel structure. These systems can be 
readily loaded with bioactive proteins and used as injectable sustained release system.[79] 
 
4.2.1.3 Thermal Crosslinking 
Mechanisms described above may be exploited for biofabrication in combination with 
sensitiveness to changes in external stimuli, especially shear force to yield shear-thinning 
systems.[64, 80] Of particular interest are systems that are liquid at room temperature, allowing 
their formulation with bioactive molecules and/or cells, but that gel at body temperature after 
their administration. Such hydrogels comprise of thermosensitive polymers which have a 
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good aqueous solubility at room temperature but are insoluble at body temperature. A main 
representative of thermosensitive polymers is poly(N-isopropylacryl amide) (PNIPAm) which 
is characterized by a cloud point in water of 32 °C. This polymer has been combined in 
different architectures with a great variety of water-soluble polymers to yield injectable 
hydrogels.[81] PNIPAm is, however, not biodegradable and therefore in recent years a number 
of biodegradable thermosensitive polymers have been described, which were subsequently 
investigated for TE,[24, 57] as well as for pharmaceutical applications.[82] 
 
4.2.2 Chemical Crosslinking 
A significant drawback of the physically crosslinked hydrogels is their poor mechanical 
properties, which may raise stability problems of a printed construct and be associated with 
difficulties in handling and its overall performance. Therefore, increasing attention has been 
given to hydrogels that are hold together by weak (reversible) physical interactions that enable 
good printability, but that can further be stabilized by chemical crosslinking post-processing. 
Chemical crosslinking, which comprises all methods that lead to hydrogel formation by 
connection of gel precursors (low molecular weight monomers or polymeric building blocks) 
through newly formed covalent bonds, may be tuned to provide hydrogels with good handling 
properties and high mechanical strength. Chemical crosslinking is usually achieved by mixing 
of two low viscous solutions with gel precursors (e.g. monomers and initiator, 
complementarily reactive gel precursors), which initiates the crosslinking reaction. This 
results in a constant increase of viscosity until the gel-point is reached and a 3D polymer 
network develops. A major drawback of this strategy for biofabrication is the need for very 
stringent control of crosslinking kinetics from low viscosity printable precursor solutions to 
the crosslinked hydrogels without blocking the nozzle during the continuous printing process. 
Yet, shape fidelity of the printed construct has to be guaranteed. One possibility to exploit 
chemical crosslinking for biofabrication is the use of reactive mixing heads (Fig. 8). 
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Importantly, these technologies should be developed in such a way that the crosslinking can 
be done under mild/physiological conditions using chemistry compatible with bioactive 
proteins and living cells. Hence, chemical crosslinking methods have to be designed in such a 
way that toxic reaction by products or non-cytocompatible monomers and hydrogel precursors 
are avoided. 
 
In order to increase the viscosity of the bioprinted gel, hydrogels have also been partially pre-
crosslinked prior to deposition.[83] As in the crosslinking process covalent bonds are formed 
and beyond the gel point the shape is irreversibly fixed, it will be particularly challenging to 
achieve the desired degree of crosslinking when employing this strategy. Others have ensured 
high viscosities and fast gelation by initiation of the crosslinking prior to the printing.[84] The 
continuous development of rheological properties over time during the printing process will 
likely affect the final shape fidelity. Consequently, chemical crosslinking is mainly used for 
post-processing fixation and stabilization of printed structures. This approach includes post-
stabilizing freshly printed hydrogel constructs, usually weakly stabilized through physical 
crosslinks, by exposure to radiation, temperature, or by post-processing reaction of 
complementary chemical groups (e.g. by Michael addition reaction[85], click chemistry[86] or 
enzymatic reactions[87]). Thus, often a cascade of gelation mechanisms and triggers are 
involved in such systems. For example, the printing of warm gelMA-based solutions that form 
physical gels upon cooling on the collector, is followed by UV-curing to obtain an irreversibly 
crosslinked gel.[57] This post-processing photo-polymerization step can lead to very fast 
crosslinking of the hydrogel and, hence, facilitates the maintenance of shape directly after 
dispensing.[24, 88] However, UV light has potentially deleterious effects on the embedded cells, 
and hence its use in biofabrication must take this into account. 
 
5. Converging Biofabrication Strategies 
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For the fabrication of customized tissue equivalents in tissue engineering, complex anatomical 
architectures with a certain degree of stiffness may need to be fabricated. Convergence of 
biofabrication approaches allows for the production of more complex architectures that 
include overhangs and internal porosity by using sacrificial materials as temporal support 
during fabrication. Moreover, reinforcing the hydrogel constructs with thermoplastic 
polymers provides strength, allowing these implants to withstand the mechanical forces they 
are potentially exposed to within the musculoskeletal system. 
 
5.1. Sacrificial Materials 
The CAM-models of complex anatomical structures could easily be derived from a 3D-scan 
of the part of interest of the human body.[1] Such models often involve overhang geometries 
due to internal cavities, or due to the outer contour of complex anatomical structures. Through 
smart rotation of the 3D design, the number of overhangs can be minimized for the AM 
process. Nevertheless, the remaining overhang geometries need to be temporarily supported, 
as the deposition of material above an empty cavity will be difficult. Preferably, the 
temporary support material can be washed away from the target structure serving as a 
sacrificial component.[89, 90] Sacrificial materials have been implemented in molding processes 
for creating microchannels in chips.[89, 91] Since these chips were fabricated from inorganic 
materials the sacrificial components could be removed with a broad spectrum of chemical 
substances. However, when support materials are a component of viable hydrogel constructs 
the sacrificial procedure should be cytocompatible. Therefore, sacrificial materials have been 
applied for realizing channel networks within hydrogel constructs, either by casting[92] or by 
combining printing and casting.[74, 90] In the latter approach, Miller et al.[90] printed a vascular 
network from carbohydrate glass, a solution of sucrose, glucose and dextran. Subsequently, a 
hydrogel was cast and crosslinked around this network and the construct was placed in culture 
medium allowing the printed carbohydrate glass to dissolve. Although this approach provides 
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exceptional control over the shape of the internal vascular network, with such casting control 
over the architecture of the surrounding hydrogel construct remains limited. In order to 
control deposition of different cell types or bioactive substances, the sacrificial material could 
be applied in a bottom-up AM approach. However, this limits the number of suitable 
biomaterials. For example, a wide range of water-soluble materials, including carbohydrate 
glass[90] and polyvinyl alcohol (PVA) are stiff enough to carry their own weight, but form 
unstable interfaces with the surrounding hydrogel target structures due to their hygroscopic 
properties. Alternatively, a thermoplastic polymer (e.g. polycaprolactone (PCL)) can be co-
deposited as a sacrificial component that forms a stable interface with the hydrogel 
construct,[93] yet such thermoplastic polymers require physical removal from the target 
structure, since dissolution using organic solvents would be detrimental the embedded cells. 
As such, the printed thermoplastic structure serves as a mold and only supports the outer 
contours.[94] Co-deposition of two stable hydrogels, on the other hand, allows for temporary 
support of internal cavities, as is the case for tubular structures.[93, 95] In order to dissolve the 
sacrificial component the target structure needs to be selectively crosslinked.[93] 
 
5.2. Combination with thermoplastic polymers 
Biofabricated hydrogel constructs for implantation usually have a lower stiffness than their 
target tissue, especially for use in the musculoskeletal system[57, 96] A stiff and coherent 
hydrogel construct will be required to withstand such challenging environments in the human 
body. Pre-culturing cells in these constructs can increase stiffness due to specific tissue matrix 
deposition.[97] Yet, this demands high cell concentrations and a substantial preculturing period. 
Disregarding the influence of incorporated cells, improving stiffness of the hydrogel itself 
could be achieved by increasing hydrogel crosslink density. Unfortunately, this compromises 
formation of new tissue partly due to impaired diffusion coefficients of nutrients and wate 
products through the hydrogel system.[22, 39, 97, 98] 
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In order to combine favorable biological and mechanical hydrogel properties, reinforcement 
of hydrogels has been achieved at different levels. Hydrogels have been reinforced by use of 
double networks (DN)[99] and interpenetrating polymer networks (IPN),[100] as well as by 
incorporation of nanoparticles[101], nanotubes[96, 101, 102] or electrospun fibers.[103-105] In these 
approaches the crosslink density of the hydrogel could remain relatively low allowing for 
adequate tissue formation. However, most of these approaches will not be compatible with 
AM processes, since fabrication requires casting or a two-step crosslinking reaction. 
Therefore, recently multiple-tool biofabrication has been developed in which hydrogel 
constructs are reinforced by co-deposited thermoplastic polymer fibers.[93, 105-108] Specifically, 
this has been achieved by combining hydrogel and PCL in robotic dispensing[106-108] and by 
combining electrospinning techniques with inkjet printing[105] or laser-induced forward 
transfer printing[109]. In this way, hydrogels can be processed at low polymer concentrations 
while shape and strength of the overall construct are secured by the thermoplastic polymer 
network. Moreover, it can be used in order to fabricate more complex shaped tissue 
constructs[93] and the Young’s modulus of the target construct can be tailored by adjusting the 
thermoplastic polymer network.[106, 108] Electrospinning produces a higher resolution of PCL 
fibers[105, 109] compared to robotic dispensing, and results in a network that better approaches 
the structure of natural ECM. However, the current solution electrospinning techniques are 
not able to control fiber deposition and the small pore size of the resulting random meshes 
limits cell migration.[110] Recently developed melt electrospinning writing techniques[111] 
address both these limitations,[112] since fibers can be deposited with high spatial resolution 
and orientation. Combining this technique with hydrogel deposition approaches will allow for 
the generation of reinforced hydrogel constructs with high control over the intricate spatial 
organization, although grafting between fibers and the hydrogel needs to be addressed in 
order to biofabricate truly integrated constructs. In addition, degradation kinetics of these 
hybrid structures should be understood and controlled. The hydrogel scaffold acts as a 
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temporary environment and degrades as the embedded cells secrete proteases and 
subsequently produce extracellular matrix proteins that defines the new tissue. In contrast, the 
polymeric reinforcement material should degrade in a significant slower rate, providing 
strength to the developing construct until the tissue has matured and at least once remodeled. 
 
6. Concluding remarks and Future Perspectives 
Current deposition and fabrication technologies allow researchers to design and build  
structures with increasingly intricate architectures. However, in achieving this, many 
concessions were made with regards to the biological aspects of the hydrogels. The overall 
lack of suitable bioinks for the generation of larger 3D constructs that replicate a certain 
degree of tissue organization is hampering both the progress in the field of biofabrication and 
its translation towards clinical application. In part, this may be due to the current lack of 
comprehensive and systematic studies that focus on the characterization of the potential 
bioinks from a physical and rheological point of view. The fact that these physical and 
rheological properties of hydrogel precursors will interact with its biological performance, 
highlights the need for novel (semi-) high throughput screening assays since new or altered 
materials will have to be re-evaluated. 
 
Maintaining high shape fidelity may compromise the biological competence and the clinical 
potential of the generated structures, due to the physicochemical demands of the hydrogel and 
the extensive fabrication times. Optimization of the environmental conditions during 
biofabrication, e.g., printing into a culture medium, may allow for longer fabrication times 
without negatively affecting the embedded cell viability. Reproduction of the tissues with 
minute detail is most likely not required,[46, 113] although, this is a relatively unexplored topic 
in the field and a deeper understanding is urgently needed to which degree the directed 
organization will contribute to the ultimate organization of the regenerated tissue. A collection 
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of deposited cells and matrix within a 3D structure is not yet a functional tissue and following 
the biofabrication, extracellular matrix deposition and remodeling are important processes to 
form functional tissue structures that will determine the ultimate success of the generated 
tissue replacement. It will take time to actually achieve the required reorganization and to 
realize functional interaction of the neo-tissue. Besides this, it remains also to be determined 
if this reorganization should fully take place after implantation or that an in vitro conditioning 
period, e.g., in a bioreactor with mechanical loading regimes or ectopically in the human body, 
should be incorporated in the approach. The inclusion of more rigid thermoplastic polymer 
fibers within hydrogel constructs, either generated by fiber deposition modeling[106] or 
electrospinning,[103, 112] may assist in taking some of the initial load-bearing, potentially 
decreasing the bioreactor culture required. 
 
For polymer chemists and material scientists, it remains a challenge to develop unique bioinks, 
taking in account the required biological competence, the physical requirements dictated by 
the biofabrication process, as well as the relative toxicity of crosslinking[114] and photo-
initiator initiator[115] agents. Promising developments are the generation of IPNs for 
biomedical applications, including those based on gelatin methacrylamide and gellan gum 
methacrylate,[37, 99] which demonstrated to have improved mechanical properties while 
allowing cellular survival. In addition, double-network (DN) hydrogels[116] are an example of 
hydrogels that have, despite their high water content (~90 wt%), unsurpassed mechanical 
strength and toughness and are, therefore, suggested as potential full tissue (cartilage) 
replacements.[117] However, care should be taken in this instance since compression resistance 
is lost after repeated compression due to breakage of the primary polymer network. Novel DN 
hydrogels have recently been developed that show partial healing capacity of the primary 
network.[118] Incorporation of cells in these hydrogel systems will still remain a challenge due 
to the limited cytocompatibility of the crosslinking agents, as well as to the two-step synthesis 
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procedure required to create these IPNs,[37, 119] although incorporation as a reinforcing 
component of a biofabricated construct can be envisioned. 
 
The range of biomaterials that could be applied as bioinks could be extended through the 
further development of biofabrication methods that can process hydrogel precursor solutions 
that rely on the addition of a crosslinking agent. Obviously, processing pre-mixed components 
is problematic due to the increasing viscosity as a result of the initiation of the crosslinking 
reaction. To avoid crosslinking within the nozzle it is very important to synchronize feed rate 
and crosslinking kinetics. 
 
An additional important challenge is the scale-up and speed of bioabrication, in order to 
manufacture constructs of clinically relevant sizes. Approaches to potentially improve 
production speed include the further convergence of biofabrication technologies, combining 
approaches with different scales of resolution (e.g., laser-based and robotic dispensing 
approaches), as well as high throughput production of smaller organized units[120] that can 
subsequently be assembled in the laboratory or in situ in to larger structures.[46] Still often a 
trade-off between resolution and speed has to be made. While relatively large constructs can 
be manufactured with robotic dispensing, scale-up issues should be considered for both laser- 
and inkjet-based systems.[46] With respect to inkjet printing, if systems were to be redesigned 
specifically for bioprinting with respect to dimensions, the process may become more reliable 
and of less impact on cell viability and function. Moreover, higher viscosities may be 
permitted as larger channels and orifices imply lower pressure drops and shear stresses, 
thereby widening the range of processable hydrogels and facilitating 3D construction. Even at 
a tenfold decrease in printing resolution (e.g. from 1200 dpi to 120 dpi), the minimum feature 
size (200 mm) may still be acceptable for many bioprinting applications. Although inkjet 
printers applied for bioprinting purposes were designed to print in 2D, 3D inkjet printers have 
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recently become commercially available. 3D inkjet printing works by jetting a photo curable 
resin in thin layers (typically 28 µm) onto a tray, followed immediately by UV curing to 
prevent spreading of the droplets. In this way, polymer parts of up to 150 mm in height have 
been fabricated. These developments clearly illustrate the enormous, yet unexplored, potential 
of inkjet technology. 
 
Taken together, biofabrication potentially allows for further automation, standardization and 
control of the generation of not only customized implants but also in vitro disease model 
which allow high-throughput studies. With the suitable bioinks, supported by advanced 
biofabrication technologies this will also allow us to perform mechanistic studies e.g. how 
cells interact with their surrounding matrix and/or cells or toxicity screening and drug testing.  
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Figures 
 
Figure 1. This review advocates a change in the paradigm of biopolymer development by 
shifting the biofabrication window. Optimal shape fidelity in biofabrication processes can 
typically be achieved with stiff hydrogels containing high polymer concentrations /or 
crosslink densities (fabrication window), however, this dense polymer network limits cell 
migration, growth and differentiation. On the other end of the spectrum, cells thrive best in 
soft hydrogels (cell culture window), which are to watery too maintain shape for fabrication 
purposes. Therefore, a biofabrication window exists for medium crosslinked hydrogels,[39] 
compromising on both biological and fabrication properties. Recently, strategies are applied 
to shift the bioprinting window, obtaining high shape fidelity with cytocompatible hydrogels. 
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Figure 2. Selected biofabrication approaches involving the use of hydrogels in form of a so 
called “bioink”. 
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Figure 3. Biofabrication examples - Aortic valve model reconstructed from micro-CT images 
(A). The root and leaflet regions rendered separately into 3D geometries (green color 
indicates valve root and red color indicates valve leaflets) and printed (B). An ovine meniscus 
reconstructed from micro-CT images (C) and printed (D). A miniaturized distal femur from a 
human knee designed using Rhino Software LxWxH: 40x35x32mm) containing a cartilage 
layer (green) and a bone component (yellow) and a support structure (white) (E) and printed 
after manual removal of the support structure (F). Reproduced with permission from Duan et 
al.[12] and Wiley (A,B), Cohen et al.[11] Liebert (C,D), and Visser et al.[93] (E, F). 
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Figure 4. Concept map of variables and relations critical to biofabrication. The hydrogel 
(polymer type(s), concentration, molecular weight and chemical composition) directly 
determines the viscosity, gelation mechanism and speed, and mechanical properties of the 
final gel. This -in combination with processing parameters, such as nozzle gauge and 
fabrication time- influence the main outcomes Printing fidelity and Cell viability and function. 
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Figure 5. Illustration of the role of viscosity in bioprinting. Gelatin methacrylamide (gelMA) 
on its own (20%) formes droplets at the nozzle (A) and deposits in flat lines that spread out on 
the surface (C). When 2.4% hyaluronic acid (HA) is added, strands can be deposited from the 
nozzle (B), resulting in a construct of four layers (D). The scale bars in A-C represent 5 mm; 
the scale bar in D is 2 mm. Reproduced with permission from Schuurman et al.[57] and Wiley. 
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Figure 6. Viscosity variation as a function of shear rate for different alginate solutions. Shear 
thinning is demonstrated by the rapid decline in viscosity as the shear rate is increased, with 
higher concentration alginate having the greatest reduction in shear viscosity. Reproduced 
with permission from Rezende et al.[65] and Wiley. 
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Figure 7. Schematic representation of shear thinning and yield stress in plotting gelatin 
methacrylamide (gelMA)/gellan gum. In the syringe the gellan chains (in white) form a 
temporary network and induce gel-like viscosity (i). Upon dispensing through a needle, the 
temporary network is broken up by shear and all polymer chains align, reducing the viscosity 
by orders of magnitude (ii). Directly after removal of shear stress, the temporary network is 
restored and the plotted filament solidifies instantly (iii). Reproduced with permission from 
Melchels et al.[67] 
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Figure 8. Graphical illustration of physical, combinational and wet-chemical crosslinking 
mechanisms for extrusion-based biofabrication. 
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Figure 9. Examples of combined deposition of thermoplastic polymers and hydrogels. 
Scanning electron microscope images of a hybrid printed polycaprolactone (PCL)/ 
poly(lactic-co-glycolic acid) (PLGA) scaffold with infused HA hydrogel (A, B). A three-
dimensional design (C) is translated to a deposition protocol, which uses (thermoplastic) PCL 
and alginate hydrogels (D). Reproduced with permission from Shim et al.[107] (A, B), 
Schuurman et al.[106] (C, D) and IOP Publishing. All rights reserved. 
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Table 1. Typical characteristics of three key dispensing approaches in biofabrication. 
 
Laser-induced 
forward transfer 
Inkjet printing 
 
 
Robotic dispensing 
 
 
Resolution ++ + +/- 
Fabrication speed 
- +/- ++ 
Hydrogel viscosity +/- - + 
Gelation speed ++ ++ +/- 
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Table 2. Hydrogels applied for fabricating 3D-structures. 
hydrogel fabrication 
technique 
polymer 
concentration 
(w/v) 
gelation method printing 
quality 
cytocompatibility reference 
 
laser-
induced 
forward 
transfer 
     
alginate  2% ionic 2 intermediate, day 
10 
[121]
 
  1% ionic a* high, day 7 [109] 
  1% ionic 3 high, day 1 [122] 
  2%/8% ionic 1/2 not studied [123] 
       
 inkjet      
alginate thermal 2% ionic 2 not reported [124] 
 piezo 0.8% ionic 2 high, day 0 [50] 
alginate/collagen type 1 thermal 1%/0.3% ionic 2 90%, day 7 [125] 
collagen type 1 not 
reported 
0.1% thermal 1 migrating cells [126] 
fibrinogen/collagen type 1 thermal 1%/0.15% enzymatic a* 82%, day 7 [105] 
poly(ethylene glycol) 
dimethacrylate 
thermal 10%; 20% photo (during print) 2 89%, day 1 [13] 
 
       
 
robotic 
dispensing 
     
agar pneumatic 5% thermal 2 not studied [72, 127] 
agarose piston-
driven 
1.5% thermal 3b* 95%, day 21 [54] 
 
piston-
driven 
5% thermal 1 95%, day 7 [25] 
 
piston-
driven 
not reported thermal (cooling of 
strand in needle) 
3 d* not studied [128] 
agarose pneumatic 4% thermal 2*b not studied [55] 
alginate piston-
driven 
10% ionic 2 89%, day 1 [63] 
 
piston-
driven 
2% ionic 2 82%, day 3 [25] 
 
piston-
driven 
2% ionic 2 75-94%, day 0 [11, 84, 129] 
 pneumatic 1.5% - 3% ionic 2 (3%) 85%, day 0 
(1.5%) 
[130]
 
 
piston-
driven 
4% ionic 2 not studied [40] 
 
piston-
driven 
2% ionic c* 70%, day 3 [106] 
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 pneumatic 3.5% ionic c* 84%, day 0 [108] 
 
piston-
driven 
4% ionic c* 94%, day 7 [131] 
 pneumatic 5% ionic 1*b not studied [55] 
 
piston-
driven 
1% ionic 2 not studied [132] 
alginate/fibrin pneumatic 6.3%/?% ionic/enzymatic 1 not studied [127] 
alginate/gelatin piston-
driven 
7.5%/5% thermal/ionic/chemical 2 95%, day 0 [133] 
atelocollagen pneumatic 3% thermal c* 95%, day10 [107] 
collagen type 1 pneumatic 0.3% thermal 2 86%, day 1 
 
[27, 134]
 
 pneumatic 0.223% pH (sodium bicarbonate) 2*e not studied [135] 
 
piston-
driven 
0.1% thermal 1 migrating cells [126] 
gelatin piston-
driven 
20% thermal/chemical 2 95%, month 1 [136] 
 
piston-
driven 
20% thermal/chemical 2/3 poor cell 
differentiation 
[137]
 
 pneumatic 7% thermal 2*d not studied [135] 
 pneumatic 2% extruded in gel phase at 
20°C 
2 not studied [55] 
gelatin methacrylamide piston-
driven 
20% thermal /photo 1 73% [57] 
gelatin/alginate piston-
driven 
6%/5% thermal/ionic 3 82%, day 7 [12] 
gelatin/alginate/chitosan piston-
driven 
15%/1.25%/2.5 enzymatic/ionic/chemical 2 proliferating 
cells, day 7 
 
gelatin/alginate/fibrinogen 
 
piston-
driven 
15%/1.25%/0.5% 
 
thermal / enzymatic/ 
ionic/ 
chemical 
2 proliferating 
cells, day 7 
[138]
 
gelatin/alginate/fibrinogen piston-
driven 
2:1:1 thermal/ionic/enzymatic 2 differentiating 
cells 
[139]
 
gelatin/chitosan 
 
piston-
driven 
5%/0.5% 
 
ionic/ 
chemical 
2 98%, month 2 [140] 
gelatin/chitosan piston-
driven 
4.6%/0.4% thermal 1 Not reported [141] 
gelatin/chitosan piston-
driven 
9%/1% thermal 2 85-97% [141] 
gelatin/fibrinogen 
 
piston-
driven 
13.3%/3.3% 
10%/5% 
6.6%/6.6% 
enzymatic 2 98%, day 0 [142] 
gelatin/Hyaluronan piston-
driven 
10%/0.5% thermal/chemical 2/3 poor cell 
differentiation 
[137]
 
gelatin methacrylamide/ 
hyaluronic acid 
piston-
driven 
20%/2.4% thermal/photo 3 82%, day 3 [57] 
gelatin 
methacrylamide/gellan 
piston-
driven 
10%/1.1% ionic/ 
thermal/photo 
3 e* 80%, day 3 [93] 
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hyaluronic acid/ 
hydroxyethyl-
methacrylate-derivatized-
dextran (dex-HEMA) 
piston-
driven 
10% photo 2 75%, day 3 [88] 
hyaluronic acid 
methacrylate (HA-
MA)/gelatin methacrylate 
(GE-MA) 
piston-
driven 
1.2%/0.3% photo (during print) 1 proliferating 
cells, day 7 
[83]
 
hyaluronic acid 
methacrylate (HA-MA) 
piston-
driven 
1.5% photo (during print) 1 not studied [83] 
Lutrol F127 piston-
driven 
25% thermal 3 2%, day 7 [25] 
 pneumatic 30% thermal 3 60%, day 0 [27] 
 
piston-
driven 
40% thermal 3d* not applicable [74] 
Lutrol piston-
driven 
25% thermal/photo 3 50%, day 3 [11, 84] 
Matrigel piston-
driven 
not reported thermal 1 High viability [143] 
methylcellulose piston-
driven 
4% thermal 1 not reported [25] 
N- isopropylamid and 
polyethylene glycol) 
pneumatic 10% thermal 2 not studied [144] 
poly(ethylene glycol) 
diacrylate 
pneumatic 25% photo 1 not studied [55] 
poly(ethylene glycol) 
diacrylate/ alginate 
piston-
driven 
20%/12.5% photo (during print) 3 near 100%, day 
21 
[44]
 
p(HPMAm-lactate)-PEG piston-
driven 
25-35% 
 
thermal /photo 3 94%, day 1 
 
[24]
 
tetraPAc piston-
driven 
1-2% michael addition 2e* high, day 28 [95] 
Printing quality rated on shape-fidelity scale: 
1= low   undefined structure 
2= intermediate  irregular pattern/fiber, 3D potential 
3= high  well-defined building material 
*a = reinforced with solution electrospun fibers 
*b = submerged fabrication technique 
*c = reinforced with co-deposited thermoplastic polymer scaffold 
*d = hydrogel is sacrificial component, no aim for direct cell encapsulation 
*e = support component used 
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Table 3. Viscosities of some hydrogel precursor solutions used for printing. 
polymer concentration 
% w/v 
viscosity 
 
(Pa.s) 
shear 
rate 
 
(s-1) 
molecular 
weight (kDa) 
reference 
sodium alginate 2 0.9 100 100-500 
(typical) 
[65]
 
3 2.0 
5 6.4 
Lutrol F127 25 0.03 - 12 [74] 
30 1.5 
35 26 600 
40 >600 000 
PE 10 0.008 200-
1300 
3.35 [13, 145] 
20 0.017    
Gelatin 10 0.02 50 50-100 [67] 
Hyaluronic acid 1.5 22 1 950 [95] 
Collagen type I 0.3 10 0.1-100 115+230 [27, 134, 146] 
GelMA/gellan 10/0.75 1 50 50-100/1000 [67] 
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Hydrogels are attractive cell carriers for regenerative medicine as they recapitulate 
several features of the natural extracellular matrix. However, biofabrication of three-
dimensional complex, tissue-like structures with high shape fidelity dictates narrow 
boundaries for the physical properties of the hydrogels applied. This review focuses on 
strategies and new developments that address these physicochemical challenges. 
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